GLP-1 research emerges
Developing research highlights the clinical impact of glucagon-like peptide-1 receptor agonists (GLP-1RA), including their potential role in cancer risk reduction and skin ageing. A study published in Annals of Oncology
Developing research highlights the clinical impact of glucagon-like peptide-1 receptor agonists (GLP-1RA), including their potential role in cancer risk reduction and skin ageing. A study published in Annals of Oncology
The Medicines and Healthcare products Regulatory Agency (MHRA), Advertising Standards Authority (ASA), and the General Pharmaceutical Council (GPhC) have released a warning to businesses against promoting newly licensed medicines and
The UK Medicines and Healthcare products Regulatory Agency (MHRA) and US Food and Drug Administration (FDA) have announced a new liaison programme. The agencies share that the roles aim to enhance day-to-day collaboration, support scientific exchange and enable
Pharmaceutical company Allergan Aesthetics, an AbbVie company, has announced Skinvive by Juvéderm has received approval from the US Food and Drug Administration (FDA) to reduce neck lines. The company shares
Artist, creative director and brand developer Russell Turner has released new publication Believe Able. According to Turner, Believe Able aims to offer healthcare and aesthetic professionals a practical framework for
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved the first glucagon-like peptide-1 (GLP-1) receptor agonist weight-loss tablet for use in the UK. The once-daily semaglutide tablet, marketed by
Treatment and skincare brand Million Dollar Facial has unveiled microneedling system Bio-Cell Trinity +. According to the company, the microneedling system combines biodegradable spicules, plant-derived exosomes and vegan polydeoxyribonucleotide (PDRN)within a
Skincare company AlumierMD has released its Gentle Foaming Cleanser. AlumierMD shares that the cleanser is targeted for both post-procedure and at-home use,developed to support compromised, sensitive skin. The product aims
Aesthetic device company Hydrafacial has reintroduced HydraScalp with Keravive. The company explains that the relaunched treatment is an evolved version of its scalp treatment, formerly known as Keravive. According to Hydrafaical,
The Advertising Standards Authority (ASA) has banned beauty retailer Beauty Pie’s LED face mask advert for making misleading antiageing claims. The ASA shares that the advert, illustrated as a poster